Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.

Cancer research - 15 Jan 2003

Biswas Debajit K, Martin Katherine J, McAlister Cliona, Cruz Antonio P, Graner Edgard, Dai Sun-chun, Pardee Arthur B

Abstract excerpt

Both the protein kinase C (alpha/beta) inhibitor Go6976 and expression of dominant-negative nuclear factor (NF)-kappaB inhibitor kinase mutants: (a) blocked the growth and caused regression of a mammary tumor insyngeneic mice; (b) inhibited epidermal growth factor (EGF)-induced activation, nuclea...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carbazoles
Share to I-kappa B Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indoles

Share to Mammary Neoplasms, Experimental

Share to Mice, Inbred A

Share to NF-kappa B

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 12543776

Genes

EGF
TNF
DAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12543776-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.PMID 12543776Read ↗

Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.Semantic proximity Read ↗

The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.Semantic proximity Read ↗

Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.Semantic proximity Read ↗

The EGF/ErbB Receptor Family and ApoptosisSemantic proximity Read ↗

Role of NF-kappaB in p53-mediated programmed cell death.Semantic proximity Read ↗

Pharmacogenomic Identification of Targets for Adjuvant Therapy with the Topoisomerase Poison CamptothecinSemantic proximity Read ↗

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.Semantic proximity Read ↗

Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells.Semantic proximity Read ↗

The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies.Semantic proximity Read ↗

Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer.Semantic proximity Read ↗

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.Semantic proximity Read ↗

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.